Preferred Name |
Teicoplanin |
|
Synonyms |
|
|
Definitions |
A glycopeptide antibiotic complex isolated from the bacterium Actinoplanes teichomyceticus. Teicoplanin inhibits peptidoglycan polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C1412 |
|
ALT_DEFINITION |
A substance used to treat bacterial infections. It belongs to the family of drugs called antibiotics. |
|
CAS_Registry |
61036-62-2 |
|
code |
C1412 |
|
Contributing_Source |
FDA |
|
definition |
A glycopeptide antibiotic complex isolated from the bacterium Actinoplanes teichomyceticus. Teicoplanin inhibits peptidoglycan polymerization, resulting in inhibition of bacterial cell wall synthesis and cell death. (NCI04) |
|
FDA_UNII_Code |
4U3D3YY81M |
|
in_subset | ||
label |
Teicoplanin |
|
Legacy Concept Name |
Teicoplanin |
|
NCI_Drug_Dictionary_ID |
38431 |
|
PDQ_Closed_Trial_Search_ID |
38431 |
|
PDQ_Open_Trial_Search_ID |
38431 |
|
Preferred_Name |
Teicoplanin |
|
prefixIRI |
NCIT:C1412 |
|
prefLabel |
Teicoplanin |
|
Semantic_Type |
Amino Acid, Peptide, or Protein Pharmacologic Substance Antibiotic |
|
UMLS_CUI |
C0145106 |
|
subClassOf |